Insider Transactions Reported by 20 Insiders of Shuttle Pharmaceuticals Holdings, Inc.

Symbol
SHPH on Nasdaq
Location
Gaithersburg, MD

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Shuttle Pharmaceuticals Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mira Jung Chief Scientific Officer $1,530,865 01 May 2024
Anatoly Dritschilo CEO and Chairman, Director, 10%+ Owner $1,484,281 14 Aug 2023
Milton Brown Director $160,553 31 Dec 2024
Steven M Richards Director $97,274 08 Aug 2025
Joshua Schafer Director $97,274 31 Dec 2024
Joseph Tung Director $85,304 08 Aug 2025
George Scorsis Director $85,304 08 Aug 2025
Oleh Nabyt Director $85,304 08 Aug 2025
William H. Adkins Former Director $85,262 29 Dec 2022
Bette Jacobs Director $62,646 13 Dec 2023
Michael Vander Hoek Chief Financial Officer $48,104 08 Mar 2024
Peter Dritschilo President and COO $3,039 29 Dec 2022
Chris Senanayake Director $1,293 29 Dec 2022
Tyvin Rich Chief Medical Officer $1,125 29 Dec 2022
Arachchige Sachin Eranga Pathigoda Director $0 12 Sep 2025
Angel Liriano Director $0 12 Sep 2025
Adam Chambers V. Director $0 08 Sep 2025
Yuying Liang Chief Financial Officer 06 Jan 2026
Chris Cooper Interim Co-CEO 11 Mar 2025
Timothy J Lorber Chief Financial Officer 08 Aug 2025

Recent Insider Transactions by Companies or Individuals for Shuttle Pharmaceuticals Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.